Targets › ACTH
1 program from 1 company in 1 trial: 1 Phase 4; Immunology; next expected readout Aug 2027.
Open in Phaseline: the race on ACTH, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Massachusetts General Hospital | Purified Cortrophin Gel Adrenocorticotropic hormone (ACTH) analog | ACTH | Phase 4 | Gout Arthritis | Aug 2027 |
Gout Arthritis (1)
small molecule (1)
Massachusetts General Hospital (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.